{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T10:40:35Z","timestamp":1772793635850,"version":"3.50.1"},"reference-count":31,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2010,12,9]],"date-time":"2010-12-09T00:00:00Z","timestamp":1291852800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[2011,1]]},"abstract":"<jats:p> <jats:bold>WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT<\/jats:bold> <\/jats:p><jats:p>\u2022\u2003General use of hormone replacement therapy (HRT) dropped drastically after 2002 when pivotal randomized trials showed increased risk of coronary artery disease and other complications with HRT.<\/jats:p><jats:p>\u2022\u2003HRT is not recommended for primary or secondary prevention of coronary heart disease and guidelines recommend discontinuation of HRT after myocardial infarction (MI).<\/jats:p><jats:p>\u2022\u2003It is unknown whether women actually discontinue HRT after MI.<\/jats:p><jats:p> <jats:bold>WHAT THIS STUDY ADDS<\/jats:bold> <\/jats:p><jats:p>\u2022\u2003Women who use HRT when they experience their MI generally continue using HRT.<\/jats:p><jats:p>\u2022\u2003We found a remarkably low increase in discontinuation after 2002, in contrast to the general drop in use of HRT.<\/jats:p><jats:p><jats:bold>AIM<\/jats:bold> To characterize the pattern of use and discontinuation of postmenopausal hormone replacement therapy (HRT) in women with myocardial infarction (MI) before and after 2002, where the general use of HRT dropped drastically subsequent to the results of the Women's Health Initiative trial.<\/jats:p><jats:p><jats:bold>METHODS<\/jats:bold> All Danish women aged \u226540 years hospitalized with MI in the period 1997 to 2005 and their use of HRT were identified by individual\u2010level\u2010linkage of nationwide registers of hospitalization and drug dispensing from pharmacies. Characteristics associated with HRT use at time of MI and subsequent HRT discontinuation were analysed by multivariable logistic regression.<\/jats:p><jats:p><jats:bold>RESULTS<\/jats:bold> In the study period, 34\u2003778 women were discharged after MI. Of these, 3979 (11.4%) received HRT at the time of MI and their most used categories of HRT were vaginal oestrogen and oral oestrogen alone (46.6% and 28.7%, respectively). The percentage of women who continued HRT during the first year after discharge was 85.0% in the period 2000\u20132002 and had decreased to 79.6% in the period 2003\u20132005. Vaginal oestrogen use was associated with overall discontinuation of HRT (odds ratio [OR] 1.37, 95% confidence interval [CI] 1.10, 1.72), whereas use of oral oestrogen alone and use of oral cyclic combined oestrogen\/progestogen were associated with change of HRT after MI (OR 2.33, 95% CI 1.10, 4.93 and OR 2.94, 95% CI 1.35, 6.39, respectively).<\/jats:p><jats:p><jats:bold>CONCLUSION<\/jats:bold> The majority of women experiencing an MI during ongoing HRT continued HRT after discharge and this pattern of HRT use did not change markedly after 2002.<\/jats:p>","DOI":"10.1111\/j.1365-2125.2010.03790.x","type":"journal-article","created":{"date-parts":[[2010,8,31]],"date-time":"2010-08-31T14:34:27Z","timestamp":1283265267000},"page":"105-115","source":"Crossref","is-referenced-by-count":5,"title":["Use and discontinuation of hormone replacement therapy in women with myocardial infarction: a nationwide study"],"prefix":"10.1111","volume":"71","author":[{"given":"Ditte\u2010Marie","family":"Bretler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter Riis","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steen Zabell","family":"Abildstr\u00f8m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Casper Haslund","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rikke","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morten Lock","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina Ken","family":"Schramm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen","family":"L\u00f8kkegaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Torp\u2010Pedersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunnar Hilmar","family":"Gislason","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,12,9]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199706193362501"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.7.605"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.3.321"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.181546"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.181940"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042192-200310010-00003"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1080\/00016340701505523"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1273"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2005.071332"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.1.47"},{"key":"e_1_2_7_12_2","unstructured":"Available athttp:\/\/www.nordclass.uu.se\/index_e.htm(last assessed April 2010)."},{"key":"e_1_2_7_13_2","first-page":"445","article-title":"The Danish prescription registries","volume":"44","author":"Gaist D","year":"1997","journal-title":"Dan Med Bull"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(02)00591-7"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(01)01109-3"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2006.12.009"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejheart.2008.05.006"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehi705"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.776823"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehn408"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/gme.0b013e31817b6132"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1080\/13697130410001713733"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1080\/13697130601024629"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/gme.0b013e31817b076a"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2005.09.051"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1080\/13697130802060455"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1080\/00016340701745418"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.a1190"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.326.7386.426"},{"key":"e_1_2_7_30_2","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/gme.0b013e3181d0edaa","article-title":"Are hot flashes linked to cardiovascular risk? It is too early to tell","volume":"17","author":"Gorodeski EZ","year":"2010","journal-title":"Menopause"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.19.1690"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39188.594282.80"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2125.2010.03790.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2125.2010.03790.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T23:22:19Z","timestamp":1697412139000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2125.2010.03790.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,9]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["10.1111\/j.1365-2125.2010.03790.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2125.2010.03790.x","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,9]]}}}